Asa Abeliovich, Md - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Molecular Mechanisms of Neurodegeneration and the Life Cycle of Dopamine Neurons, Neurobiology of Disease, Stem Cell Biology

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Abeliovich A, Hefti F, Sevigny J. Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations. Journal of Parkinson's Disease. PMID 34151863 DOI: 10.3233/JPD-212739  0.328
2017 Liu Z, Bryant N, Kumaran R, Beilina A, Abeliovich A, Cookson MR, West AB. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Human Molecular Genetics. PMID 29177506 DOI: 10.1093/Hmg/Ddx410  0.4
2017 Inoue K, Oliveira LMA, Abeliovich A. CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts. Cell Reports. 21: 1727-1736. PMID 29141208 DOI: 10.1016/J.Celrep.2017.10.075  0.437
2016 Abeliovich A, Gitler AD. Defects in trafficking bridge Parkinson's disease pathology and genetics. Nature. 539: 207-216. PMID 27830778 DOI: 10.1038/Nature20414  0.49
2016 Kuwahara T, Inoue K, D'Agati VD, Fujimoto T, Eguchi T, Saha S, Wolozin B, Iwatsubo T, Abeliovich A. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts. Scientific Reports. 6: 29945. PMID 27424887 DOI: 10.1038/Srep29945  0.503
2016 Abeliovich A, Rhinn H. Parkinson's disease: Guilt by genetic association. Nature. PMID 27096361 DOI: 10.1038/Nature17891  0.361
2014 Qiang L, Fujita R, Yamashita T, Angulo S, Rhinn H, Rhee D, Doege C, Chau L, Aubry L, Vanti WB, Moreno H, Abeliovich A. Retraction Notice to: Directed Conversion of Alzheimer's Disease Patient Skin Fibroblasts into Functional Neurons. Cell. 157: 514. PMID 28683328 DOI: 10.1016/J.Cell.2014.03.002  0.307
2014 Abeliovich A. Neurological disorders: Quality-control pathway unlocked. Nature. 510: 44-5. PMID 24899302 DOI: 10.1038/510044A  0.381
2014 Doege CA, Abeliovich A. Dementia in a dish. Biological Psychiatry. 75: 558-64. PMID 24629668 DOI: 10.1016/J.Biopsych.2014.01.007  0.355
2014 Qiang L, Inoue K, Abeliovich A. Instant neurons: directed somatic cell reprogramming models of central nervous system disorders. Biological Psychiatry. 75: 945-51. PMID 24525100 DOI: 10.1016/J.Biopsych.2013.10.027  0.426
2013 Inoue K, Rispoli J, Yang L, Macleod D, Beal MF, Klann E, Abeliovich A. Coordinate regulation of mature dopaminergic axon morphology by macroautophagy and the PTEN signaling pathway. Plos Genetics. 9: e1003845. PMID 24098148 DOI: 10.1371/Journal.Pgen.1003845  0.592
2013 Qiang L, Fujita R, Abeliovich A. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. Neuron. 78: 957-69. PMID 23791192 DOI: 10.1016/J.Neuron.2013.06.002  0.428
2013 MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, MacCabe BD, Marder KS, Honig LS, Clark LN, Small SA, Abeliovich A. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron. 77: 425-39. PMID 23395371 DOI: 10.1016/J.Neuron.2012.11.033  0.69
2012 Rhinn H, Qiang L, Yamashita T, Rhee D, Zolin A, Vanti W, Abeliovich A. Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nature Communications. 3: 1084. PMID 23011138 DOI: 10.1038/Ncomms2032  0.438
2012 Inoue K, Rispoli J, Kaphzan H, Klann E, Chen EI, Kim J, Komatsu M, Abeliovich A. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway. Molecular Neurodegeneration. 7: 48. PMID 22998728 DOI: 10.1186/1750-1326-7-48  0.432
2011 Qiang L, Fujita R, Yamashita T, Angulo S, Rhinn H, Rhee D, Doege C, Chau L, Aubry L, Vanti WB, Moreno H, Abeliovich A. Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell. 146: 359-71. PMID 21816272 DOI: 10.1016/J.Cell.2011.07.007  0.462
2011 Abeliovich A. Analysis of iPS cell models of Alzheimer’s disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.307  0.315
2010 Abeliovich A. Parkinson's disease: Mitochondrial damage control. Nature. 463: 744-5. PMID 20148026 DOI: 10.1038/463744A  0.403
2010 Abeliovich A. Stem cells and Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.521  0.318
2009 Abeliovich A, Doege CA. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron. 61: 337-9. PMID 19217371 DOI: 10.1016/J.Neuron.2009.01.024  0.359
2009 Inoue K, Rispoli J, Abeliovich A. Forebrain neuron-specific Atg7-deficient mice display tau pathology Alzheimers & Dementia. 5: 399. DOI: 10.1016/J.Jalz.2009.04.1065  0.381
2007 Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science (New York, N.Y.). 317: 1220-4. PMID 17761882 DOI: 10.1126/Science.1140481  0.345
2007 Abeliovich A. Parkinson's disease: pro-survival effects of PINK1. Nature. 448: 759-60. PMID 17700685 DOI: 10.1038/448759A  0.424
2007 Abeliovich A, Hammond R. Midbrain dopamine neuron differentiation: factors and fates. Developmental Biology. 304: 447-54. PMID 17331494 DOI: 10.1016/J.Ydbio.2007.01.032  0.544
2006 MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron. 52: 587-93. PMID 17114044 DOI: 10.1016/J.Neuron.2006.10.008  0.71
2006 Abeliovich A, Flint Beal M. Parkinsonism genes: culprits and clues. Journal of Neurochemistry. 99: 1062-72. PMID 16836655 DOI: 10.1111/J.1471-4159.2006.04102.X  0.601
2006 Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH, Cha JH, Gether U, Wang H, Abeliovich A. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proceedings of the National Academy of Sciences of the United States of America. 103: 2874-9. PMID 16477036 DOI: 10.1073/Pnas.0511153103  0.425
2006 Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiology of Disease. 21: 541-8. PMID 16298531 DOI: 10.1016/J.Nbd.2005.08.018  0.457
2005 Staropoli JF, Abeliovich A. The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons. Journal of Molecular Neuroscience : Mn. 27: 175-83. PMID 16186628 DOI: 10.1385/Jmn:27:2:175  0.764
2004 Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. Plos Biology. 2: e362. PMID 15502874 DOI: 10.1371/Journal.Pbio.0020362  0.678
2004 Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. Plos Biology. 2: e327. PMID 15502868 DOI: 10.1371/Journal.Pbio.0020327  0.69
2003 Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron. 37: 735-49. PMID 12628165 DOI: 10.1016/S0896-6273(03)00084-9  0.713
Show low-probability matches.